Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome profiling of skeletal muscles from Korean patients with Bethlem myopathy. | Medicine (Baltimore) | 2023 | 36862922 | PubTator, text mining | PubMed |
| CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma. | PLoS One | 2023 | 36862682 | PubTator, text mining | PubMed |
| A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen-deuterium exchange plus mass spectrometry. | Res Pract Thromb Haemost | 2023 | 36852110 | PubTator, text mining | PubMed |
| Structural modelling of human complement FHR1 and two of its synthetic derivatives provides insight into their in-vivo functions. | Comput Struct Biotechnol J | 2023 | 36851916 | PubTator, text mining | PubMed |
| Remote ischemic conditioning-induced hyperacute and acute responses of plasma proteome in healthy young male adults: a quantitative proteomic analysis. | Chin Med J (Engl) | 2023 | 36848171 | PubTator, text mining | PubMed |
| F8 gene inversion and duplication cause no obvious hemophilia A phenotype. | Front Genet | 2023 | 36845383 | PubTator, text mining | PubMed |
| Personalizing Care for Critically Ill Adults Using Omics: A Concise Review of Potential Clinical Applications. | Cells | 2023 | 36831207 | PubTator, text mining | PubMed |
| Complement as a Biomarker for Systemic Lupus Erythematosus. | Biomolecules | 2023 | 36830735 | PubTator, text mining | PubMed |
| Profiling the Immune Response to Periprosthetic Joint Infection and Non-Infectious Arthroplasty Failure. | Antibiotics (Basel) | 2023 | 36830206 | PubTator, text mining | PubMed |
| Differential proteomic patterns of plasma extracellular vesicles show potential to discriminate β-thalassemia subtypes. | iScience | 2023 | 36824279 | PubTator, text mining | PubMed |
| Genetic adaptation to pathogens and increased risk of inflammatory disorders in post-Neolithic Europe. | Cell Genom | 2023 | 36819665 | PubTator, text mining | PubMed |
| Three different pathways of IgM-antibody-dependent hemolysis are mainly regulated by complement. | Front Immunol | 2023 | 36817469 | PubTator, text mining | PubMed |
| The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets. | Front Med (Lausanne) | 2023 | 36814775 | PubTator, text mining | PubMed |
| Nanobody-mediated complement activation to kill HIV-infected cells. | EMBO Mol Med | 2023 | 36799046 | PubTator, text mining | PubMed |
| Knockout of AMD-associated gene POLDIP2 reduces mitochondrial superoxide in human retinal pigment epithelial cells. | Aging (Albany NY) | 2023 | 36795578 | PubTator, text mining | PubMed |
| Inflammation balance in skeletal muscle damage and repair. | Front Immunol | 2023 | 36776867 | PubTator, text mining | PubMed |
| Current Knowledge of the Molecular Pathogenesis of Cutaneous Lupus Erythematosus. | J Clin Med | 2023 | 36769633 | PubTator, text mining | PubMed |
| The Sertoli Cell Complement Signature: A Suspected Mechanism in Xenograft Survival. | Int J Mol Sci | 2023 | 36768217 | PubTator, text mining | PubMed |
| Disrupted metabolic signatures in amniotic fluid associated with increased risk of intestinal inflammation in cesarean section offspring. | Front Immunol | 2023 | 36761749 | PubTator, text mining | PubMed |
| Quantitative fluorescence resonance energy transfer-based immunoassay for activated complement C1s. | Front Immunol | 2023 | 36761732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=22